Retro Biosciences
About:
Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.
Website: https://retro.bio
Twitter/X: RetroBio
Top Investors: Sam Altman
Description:
Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.
Total Funding Amount:
$180M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2021-01-01
Contact Email:
hi(AT)retro.bio
Founders:
Joe Betts-Lacroix
Number of Employees:
11-50
Last Funding Date:
2022-04-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai